Heat shock proteins (HSPs) 
Introduction
Heat shock proteins (HSPs) are highly conserved and functionally interactive chaperone proteins that maintain protein homeostasis in all living organisms [1] . Heat shock cognate (HSC) proteins are constitutively synthesized, whereas others are expressed following stress. A variety of environmental or physiological stresses, such as heat shock, hypoxia, reactive oxygen species and virus transformation, can induce HSPs expression [2, 3] . HSPs act in many fundamental cellular processes, including the catalysation of substrate refolding, the prevention of irreversible aggregation of unfolded proteins, the maturation of nuclear hormone receptors and other signalling molecules, vesicle formation and protein trafficking [4] [5] [6] [7] . According to sequence homology, HSPs can be classified into different subfamilies. Two well-characterized subgroups of HSPs are the HSP70 family and HSP90 family. The HSP70 family includes at least 11 distinct proteins in human beings, such as HSP70, HSP70A, HSP70B, GRP78, GRP75 and HSP75 [8] . The HSP90 family consists of at least nine proteins in human, such as HSP90, HSP90␣, HSP90␤, HSP86, HSP84 and HSP83 [9] . In addition, another two large HSP families, HSP100 and HSP60, are [10] [11] [12] . High levels of HSP70 and HSP90 expression confer enhanced survival and drug resistance [13, 14] . Many client proteins of HSP70 and HSP90 are critical components of diverse signalling pathways. For example, the direct interaction among HSP70, HSP90 and glucocorticoid receptor is critical for efficient hormone binding and subsequent transcriptional activation [15] . Recent studies from in vivo yeast system and in vitro mammalian cell-free system also indicate that progesterone receptor requires the molecular chaperone HSP90 for efficient ligand binding [16] . In addition to hormone receptors, another important set of client proteins of both HSP70 and HSP90 is protein kinases, such as c-raf, c-src and the receptor tyrosine kinase ErbB2 [17, 18] . GRP78 shares 60% amino acid homology with HSP70, but it is distinct from HSP70 in that it is generally non-inducible or only weakly inducible by heat [19, 20] . [25, 26] . Preclinical studies have demonstrated that the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin possesses potent anti-tumour activity [27] . In addition, the bioflavonoid quercetin could inhibit HSP70 expression by blocking heat shock transcrition factor (HSF) 1 Fig. 2A) . In addition, quercetin induced CHOP/GADD153 expression (Fig. 2B) 
. A number of functionally important HSPs have been identified. Based on the molecular mass, HSPs can be generally classified into large and small HSPs. Small HSPs include HSP27, HSP 26, HSP22 and HSP30

5Ј-CTGGGTACATTTGATCTGACT-3Ј (forward) and 5Ј-GCATCTTGGTG-GCTTTCCAGC-3Ј (reverse). The primers for human HSP70 are as follows: 5Ј-CTCCAGCATCCGACAAGAAGC-3Ј (forward) and 5Ј-ACGGTGTTGTGGGG -GTTCA-3Ј (reverse). Relative quantification with the comparative threshold cycle (C t) was done using the ⌬⌬C t method. The amount of GRP78 or HSP70 gene normalized to the endogenous reference gene (␤-actin) is given by 2 Ϫ⌬C t , where ⌬C t is C t (GRP78 or HSP70) -C t (␤-actin).
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. During the UPR, a transient translation arrest is induced upon phosphorylation of the eukaryotic initiating factor 2␣ (eIF2␣) by PERK. The phosphorylation of eIF2␣ was observed after treatment of breast cancer cells with quercetin for 1 hr (Fig. 2C). Thus, quercetin is identified as a novel inducer of the UPR.
Since HSP70 is not the only target of quercetin, we then confirmed that HSP70 down-regulation led to the UPR by suppressing HSP70 expression with siRNA against HSP70. The suppression of HSP70 with siRNA resulted in a substantial decrease in HSP70 levels and significant increase in GRP78 and CHOP levels. In addition, HSP70 knockdown induced XBP-1 splicing (Fig. 2D) (Fig. 3A) . Similar effects were observed in siHsp70-transfected cells (Fig. 3B) (Fig. 3C) . These results imply that the activation of pro-apoptotic arms of the UPR may contribute to quercetininduced apoptosis. Fig. 4A and  B ). An in parallel Western blot analysis of protein lysates from untreated cells transfected with siCtrl and siGRP78 confirmed that GRP78 expression was significantly inhibited by siGRP78 (Fig. 4B) (Fig. 4C) . These data indicate that suppression of GRP78 expression may lead to increased sensitivity of breast cancer cells to quercetin. [29] . To (Fig. 5) . Similar results were obtained when we used WST1 assays to measure the cytotoxity induced by treatment with EGCG, quercetin or both (Fig. 6) .
Fig. 2 Induction of the unfolded protein response by bioflavonoid quercetin and HSP70 knockdown in T47D cells. (A) Western blot analysis of the expression of spliced XBP-1 (XBP-1s) in response to quercetin treatment. Cells were treated with indicated doses of quercetin for 6 hrs. Cell lysates were subjected to SDS-PAGE, and then blotted with anti-XBP-1 antibody. (B) Western blot analysis of CHOP expression in response to quercetin treatment. Cells were treated with indicated doses of quercetin for 24 hrs. Cell lysates were subjected to SDS-PAGE, and then blotted with anti-CHOP antibody. (C) Western blot analysis of eIF2␣ phosphorylation in response to quercetin treatment. Cells were treated with quercetin for 1 hr and 2 hrs. Cell lysates were subjected to SDS-PAGE, and then blotted with anti-phosphorylated eIF2␣ antibody. (D) Cells were transfected with control siRNA (siCtrl) or the siRNA targeting Hsp70 (siHsp70). Cell lysates were subjected to SDS-PAGE, and then blotted with anti-GRP78, anti-CHOP, anti-XBP-1 and anti-HSP70 antibodies. (E) Cells were treated with or without 10 M LY294002, 200 nM wortmanin and 100 M quercetin for 24 hrs. Cell lysates were subjected to SDS-PAGE, and then blotted with anti-GRP78, anti-CHOP and anti-XBP-1 antibodies.
Fig. 3 Effects of quercetin and HSP70 knockdown on pro-apoptotic components of the UPR. (A) T47D cells were treated with or without 100 M quercetin for 24 hrs. Cell lysates were subjected to SDS-PAGE, and then blotted with anti-cleaved caspase-3, -4, -7 and PARP antibodies, and anti-phospho-JNK antibody. (B) T47D cells were transfected with control siRNA (siCtrl) or the siRNA targeting Hsp70 (siHsp70). Cell lysates were subjected to SDS-PAGE, and then blotted with anti-cleaved caspase-3, -4, -7 antibodies and anti-phospho-JNK antibody. (C) T47D
apoptosis, the effect of JNK inhibitor, caspase-3 and caspase-7 inhibitor on quercetin-induced apoptosis was examined by flow cytometry. Treatment of T47D cells with JNK inhibitor SP600125 partially blocked quercetin-induced apoptosis. More importantly, treatment of the cells with caspase-3 and caspase-7 inhibitor z-DEVD-fmk inhibited quercetin-induced apoptosis to more dramatic extent
Abrogation of GRP78 induction sensitizes breast cancer cells to quercetin
Since GRP78 represents a pro-survival arm of the UPR, the induction of GRP78 by quercetin may contribute to increased resistance to quercetin-induced tumour cells death. To test whether breast cancer cells depend on GRP78 for protection against quercetinmediated cell death, breast cancer cells were transfected with siRNA against GRP78 (siGRP78) or the negative control siRNA (siCtrl), followed by treatment with or without quercetin. Hoechst 33342 staining was done to evaluate the drug sensitivity of the siGRP78-transfected cells. The results demonstrated that abrogation of GRP78 induction caused a significant increase in quercetininduced apoptosis in both T47D and MCF-7 cell lines (
In addition, we examined the effect of GRP78 knockdown on quercetin-induced activation of caspase-3, caspase-7 and JNK. Whereas GRP78 knockdown did not induce the activation of caspase-3, caspase-7 and JNK in non-treated cells, it caused a significant increase in quercetin-induced activation of caspase-3, caspase-7 and JNK (Fig. 4D). These data imply that suppression of the pro-survival molecule GRP78 may lead to an increase in the activation of pro-apoptosis molecules by quercetin.
Synergistic promotion of breast cancer cells death by EGCG and quercetin
The above-mentioned results imply that down-regulation of GRP78 by compounds directed against GRP78 expression or activity could lead to increased sensitivity of breast cancer cells to quercetin. Previous studies have identified the major component of green tea, EGCG, as a natural compound that directly interacts with the ATP-binding domain of GRP78, blocks its interaction with procaspase-7 and suppresses the protective function of GRP78
In (Fig. 7) . [15, 33] . HSP70 up-regulation is observed in a variety of aggressive tumours. The connection between HSP70 and the oncogenic potential of tumour cells suggests that HSP70 may be a potential molecular target for cancer therapy or chemoprevention [25] . The bioflavonoid quercetin could suppress HSP70 expression. Quercetin displays anti-tumour activities in several types of cancer [28, 34] , but the exact mechanisms underlying these activities remains incompletely understood. This study has shown that HSP70 down-regulation with both quercetin and siRNA resulted in the activation of UPR, with both the pro-survival arm and the pro-apoptotic arm being involved.
Discussion
HSP70 belongs to a family of proteins that play diverse roles in many different cellular processes, including protein folding, trafficking and the assembly/disassembly of multi-proteins complexes [4]. Previous studies have established a role for HSP70 in potentiating signal transduction and in protecting cells from stresses-induced death
The UPR is generally triggered by disruption in ER homeostasis. ER resides in the secretory pathway and is responsible for binding [35] . The quality of proteins in the ER is tightly controlled by resident ER chaperone and folding enzymes [36, 37] [29] . Treatment with EGCG sensitizes malignant glioma cells to temozolomide [29] . 
